12.02.21
RoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry, has completed the previously-announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors.
Terms of the transaction were not disclosed.
"RoundTable has been a tremendous partner for Revision Goodier since their initial acquisition of the Company in 2016,” said Maria Carell, chief executive officer of Revision Goodier. “They have supported strategic investments in the Company to meaningfully accelerate our organic revenue and earnings growth. We now look forward to entering our next phase of growth with Gryphon."
Revision Skincare, one of the first brands in the US to be recommended and sold by skincare professionals, is known for its scientifically proven formulations, changing the way clinical skincare results are achieved. Revision offers products that enable patients and consumers to achieve great skin without compromising the skin's long-term health. The portfolio includes well-known franchises such as Nectifirm, Intellishade, DEJ and Revox.
Goodier Cosmetics is a leading topical contract development and manufacturing organization with a long history of creating quality products with significant commercial success. Goodier is known for developing innovative formulations that utilize the latest ingredients and technologies, and offering a full turnkey experience, from concept to final packaging. Goodier's customers include high-growth emerging brands as well as established market-leading skincare brands.
"On behalf of RoundTable and our investors, I would like to thank the outstanding management team and dedicated employees of Revision Goodier for helping to create such a valuable business," said Pierre Frechette, managing partner of RoundTable and Chairman of Revision Goodier. "We believe that Gryphon will be an excellent partner for the Company and its employees and customers going forward."